Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Enhanced stability of tristetraprolin mRNA protects mice against immune-mediated inflammatory pathologies.
Computerised cognitive training in acquired brain injury: A systematic review of outcomes using the International Classification of Functioning (ICF).
Abundant kif21b is associated with accelerated progression in neurodegenerative diseases.
Modifiable environmental factors in multiple sclerosis.
Osmotic Demyelination Syndrome as the Initial Manifestation of a Hyperosmolar Hyperglycemic State.
A pilot, longitudinal, 24-week study to evaluate the effect of interferon beta-1a subcutaneous on changes in susceptibility-weighted imaging-filtered phase assessment of lesions and subcortical deep-gray matter in relapsing-remitting multiple sclerosis.
Viral exposures and MS outcome in a prospective cohort of children with acquired demyelination.
JC virus-iLOV fluorescent strains enable the detection of early and late viral protein expression.
Paucity of natural killer and cytotoxic T cells in human neuromyelitis optica lesions.
Serum concentration of immunoglobulin G-type antibodies against the whole Epstein-Barr nuclear antigen 1 and its aa35-58 or aa398-404 fragments in the sera of patients with systemic lupus erythematosus and multiple sclerosis.
A rare case of Balo concentric sclerosis showing unusual clinical improvement and response with oral prednisolone.
Recall strategies for the verbal fluency test in patients with multiple sclerosis.
Evaluation of McDonald MRI criteria for dissemination in space in Korean patients with clinically isolated syndromes.
New insights in the pathogenesis of multiple sclerosis-role of acrolein in neuronal and myelin damage.
Merck Loses Protection for Patent on Zocor
Gene expression profiling of the response to interferon Beta in epstein-barr-transformed and primary B cells of patients with multiple sclerosis.
DNA Damage, DNA Repair, Aging, and Neurodegeneration.
Role of microRNAs in the regulation of innate immune cells under neuroinflammatory conditions.
Acute and Chronic Management of Neuromyelitis Optica Spectrum Disorder.
A subject-specific framework for in vivo myeloarchitectonic analysis using high resolution quantitative MRI.
A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).
Rational Design and Synthesis of Altered Peptide Ligands based on Human Myelin Oligodendrocyte Glycoprotein 35-55 Epitope: Inhibition of Chronic Experimental Autoimmune Encephalomyelitis in Mice.
Heterogeneous induction of microglia M2a phenotype by central administration of interleukin-4.
Polysialic acid as an antigen for monoclonal antibody HIgM12 to treat multiple sclerosis and other neurodegenerative disorders.
The therapeutic effect of Avonex, Rebif and Betaferon on quality of life in multiple sclerosis.
Pages
« first
‹ previous
…
481
482
483
484
485
486
487
488
489
…
next ›
last »